Results 281 to 290 of about 26,112,494 (338)

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

Nature Medicine, 2016
Jing He, Xia Zhang, Yunbo Wei, Xiaolin Sun, Yaping Chen, Jun Deng, Yuebo Jin, Y. Gan, Xin Hu, R. Jia, Chuanhui Xu, Zhaohua Hou, Y. A. Leong, Lei Zhu, Jinhong Feng, Y. An, Yuan Jia, Chun Li, Xu Liu, H. Ye, L. Ren, Ru Li, H. Yao, Yu-hui Li, Shi Chen, Xuewu Zhang, Yin Su, Jianping Guo, N. Shen, E. Morand, Di Yu, Zhanguo Li   +31 more
semanticscholar   +1 more source

Interleukin-2

Cancer Investigation, 1989
openaire   +3 more sources

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

New England Journal of Medicine, 1988
S. Rosenberg, B. S. Packard, P. Aebersold, D. Solomon, S. Topalian, S. T. Toy, P. Simon, M. Lotze, James C. Yang, C. Seipp, Colleen G. Simpson, C. Carter, S. Bock, D. Schwartzentruber, John P. Wei, D. White   +15 more
semanticscholar   +1 more source

Interleukin-2: inception, impact, and implications.

Science, 1988
Kendall A. Smith
semanticscholar   +1 more source

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.

Journal of Clinical Oncology, 1999
M. Atkins, M. Lotze, J. Dutcher, R. Fisher, G. Weiss, K. Margolin, J. Abrams, M. Sznol, D. Parkinson, M. Hawkins, C. Paradise, L. Kunkel, S. Rosenberg   +12 more
semanticscholar   +1 more source

Interleukin 2

Reactions, 1988
E, Bijvank, J, van Loo
  +5 more sources

The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

Nature reviews. Immunology, 2015
D. Klatzmann, A. Abbas
semanticscholar   +1 more source

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Cell, 1993
B. Sadlack, H. Merz, H. Schorle, A. Schimpl, A. Feller, I. Horak   +5 more
semanticscholar   +1 more source

Interleukin-2 and the Interleukin-2 Receptor Complex

2015
G N, Gaulton, P, Williamson
openaire   +2 more sources

Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.

Journal of Affective Disorders, 2012
Yang Liu, R. Ho, A. Mak
semanticscholar   +1 more source